In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...

Jaguar’s rebranding was striking in its departure from the familiar cues that had defined the brand for decades. The iconic ...

Jaguar has experienced a steep drop in European sales following a major rebranding and product shift. Stock performance ...

JLR's turbulent journey under Tata Motors, facing challenges in revenue, EBIT margins, and market access amid global ...

In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally approved for CID, to regulatory approval and commercialization ...

BIG Bull is entering the competitive Indian aviation market with Akasa Airlines. This video breaks down their business strategy and what it means for the industry.

Tata Motors continues to report a decline in UK sales for its Jaguar Land Rover (JLR) unit, with zero new Jaguar vehicle ...

Jaguar’s rebranding is not related to a sales decline. The brand had long anticipated a period when its current range would ...

Jaguar, the iconic British luxury carmaker, is experiencing a notable downturn in sales. A controversial rebranding ...

We knew Jaguar’s rebranding strategy was disastrous for the brand, but new hard data shows just how badly sales tanked. While ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs Jaguar is exploring the ...

Jaguar's European vehicle sales crash to just 49 units in April after rebrand distances brand from performance roots.